Evidence map›Paper›PMID 28078024›Full record

ArticleAmerican journal of translational research2016

Neuroprotective effect of picroside II in brain injury in mice.

Yida Wang, Wei Fang, Liang Wu, Xueya Yao, Suzhen Wu, Jie Wang, Zhen Xu, Fubo Tian, Zhenzhou He, Bin Dong

Open access · greenAbstract read
In one paragraph

Article in American journal of translational research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Yida WangDepartment of Neurosurgery, The First Affiliated Hospital of Dalian Medical University Dalian, China.
Wei FangDepartment of Medicine, Hebei North University Zhangjiakou, Hebei, China.
Liang WuJiangsu Province Key Laboratory of Anesthesiology and Jiangsu Province Key Laboratory of Anesthesia and Analgesia Application Technology, Xuzhou Medical University Xuzhou, China.
Xueya YaoDepartment of Medicine, Hebei North University Zhangjiakou, Hebei, China.
Suzhen WuDepartment of Anesthesiology, Ningxiang People's Hospital of Hunan Province Ningxiang, Hunan, China.
Jie WangDepartment of Neurosurgery, The First Affiliated Hospital of Dalian Medical University Dalian, China.
Zhen XuDepartment of Neurosurgery, The First Affiliated Hospital of Dalian Medical University Dalian, China.
Fubo TianDepartment of Anesthesiology, Shanghai Obstetrics and Gynecology Hospital, Fudan University Shanghai, China.
Zhenzhou HeDepartment of Anesthesiology and ICU, South Campus, Renji Hospital School of Medicine, Shanghai Jiao Tong University China.
Bin DongDepartment of Neurosurgery, The First Affiliated Hospital of Dalian Medical University Dalian, China.
Dalian Medical University · CNHebei North University · CNJiangxi Pingxiang People's Hospital · CNObstetrics and Gynecology Hospital of Fudan University · CNRenji Hospital · CNXuzhou Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Various types of brain injury which led to the damage of brain tissue structure and neurological dysfunction continues to be the major causes of disability and mortality. Picroside II (PII) possesses a wide range of pharmacological effects and has been proved to ameliorate ischemia and reperfusion injury of kidney and brain. However, critical questions remain about other brain injuries. We investigated the protective effect of PII in four well-characterized murine models of brain injury. Models showed a subsequent regional inflammatory response and oxidative stress in common, which might be improved by the administration of PII (20 mg/kg). Meanwhile, a series of morphological and histological analyses for reinforcement was performed. In traumatic, ischemic and infectious induced injuries, it was observed that the survival rate, apoptosis related proteins, Caspase-3, and the expression of acute inflammatory cytokines (IL-1β, IL-6 and TNF-α) were significantly alleviated after PII injection, but PII treatment alone showed no effect on them as well. The western blot results indicated that TLR4 and NF-κB were clearly downregulated with PII administration. In conclusion, our results suggested that PII with a recommended concentration of 20 mg/kg could provide neuroprotective effects against multi-cerebral injuries in mice by suppressing the over-reactive inflammatory responses and oxidative stress and attenuating the damage of brain tissue for further neurological recovery.

Indexed as

brain injuryinflammatory cytokinesoxidative stressPicroside II

Identifiers

PMID28078024
PMCPMC5209504
OpenAlexW2962839234

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.